Jeff Galvin Presents at NABOE CEO Series

Jeff Galvin, American Gene Technologies® CEO, spoke at the NABOE CEO Networking Series. Jeff discusses the economics of biotech in the DMV region and HIV research in Montgomery County. Recently, AGT™ spun-off Addimmune, a new company singularly focused on finding a potential cure for HIV with gene therapy. This NABOE conference series features the region’s top entrepreneurs, politicians, and industry leaders. NABOE provides invigorating discussions and solutions for many of the region’s business owners where they can relax and network, experience informative presentations, and supercharge their business objectives and efforts. NABOE Social Media Channels: Facebook:   / naboe.org   LinkedIn:   / national-association-of-business-owners-&-...   About American Gene Technologies: American Gene Technologies is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of gene therapies to cure infectious diseases, cancers, and inherited disorders. Its mission is to transform people's lives through genetic medicines that rid the body of disease. Visit our website: https://www.americangene.com Follow AGT on Social Media: Facebook:   / amerigene   Twitter:   / americangene   LinkedIn:   / american-gene-technologies-international-inc   Instagram:   / americangenetechnologies   Subscribe to AGT’s Newsletter: https://bit.ly/3ughPNR Follow Jeff Galvin on Social Media: Twitter: @jeffreygalvin -   / jeffreygalvin   LinkedIn:   / jeff-galvin   Follow Addimmune on Social Media: Facebook:   / addimmune   Twitter:   / addimmune   LinkedIn:   / addimmune   Instagram:   / addimmune   About Addimmune Addimmune was founded in 2023 to cure HIV with promising gene therapy technologies. Building upon the success of American Gene Technologies’ HIV clinical trial, Addimmune is solely focused on developing and commercializing an effective and lasting cure for HIV. Learn more about Addimmune in this video:    • Addimmune Pursues a Cure for HIV with Gene...